EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overexpression of ATase1 and ATase2 disrupts the secretome and causes a progeria phenotype

Tzu-Lin Cheng, Feixuan Wu iD, Md Ezazul Haque, Abigail R Thiel, Danqing Wang iD, Jeffrey J Helgager, Lingjun Li iD, Luigi Puglielli iD

Life Science Alliance · 2025

DOI: 10.26508/lsa.202503378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Tzu-Lin Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA. Hauptthemen laut MEDLINE: Progeria, Acetyltransferases, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nε-lysine acetylation in the lumen of the ER requires two acetyltransferases, ATase1/NAT8B and ATase2/NAT8. They are type II membrane proteins and belong to the larger GNAT superfamily of acetyltransferases. Their enzymatic activity is tightly coupled to the import of acetyl-CoA in the lumen of the ER by AT-1/SLC33A1. Gene duplication events involving 3q25.31 (harboring AT-1/SLC33A1 ) and 2p13.1 (harboring ATase1/NAT8B and ATase2/NAT8 ) are associated with autism spectrum disorder with intellectual disability and progeria-like dysmorphism. Here, we report the generation and phenotypic characterization of mice with systemic overexpression of ATase1 (ATase1 sTg) and ATase2 (ATase2 sTg). Overexpression of either ATase at conception was found to be lethal while overexpression at birth was found to cause a progeria-like phenotype that included skin alterations, lordokyphosis, reduced bone density, sarcopenia, splenomegaly, adenomegaly, and systemic inflammation. The phenotype of ATase1 sTg mice displayed incomplete penetrance, while the phenotype of ATase2 sTg displayed full penetrance and was more severe. Mechanistically, the phenotype was linked to altered dynamics of the secretory pathway with defects affecting the quality of the secretome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProgeriaAcetyltransferasesMembrane ProteinsAnimalsMicePhenotypeDisease Models, AnimalMaleFemaleHumansMice, Transgenic

Substanzen

AcetyltransferasesMembrane Proteins

Autor:innen und Institutionen

  • Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA.
  • Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.
  • Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI, USA.
  • School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.
  • School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA lp1@medicine.wisc.edu.

ORCID-Profile: Feixuan Wu, Danqing Wang, Lingjun Li, Luigi Puglielli

Förderung

  • NIH HHS
  • NIDDK NIH HHS
  • NCRR NIH HHS
  • NIGMS NIH HHS
  • NIA NIH HHS
  • NICHD NIH HHS
  • NINDS NIH HHS
  • HHS | NIH | National Institute of Neurological Disorders and Stroke

Zitieren

APA

Cheng, T. L., Wu, F., Haque, M. E., Thiel, A. R., Wang, D., Helgager, J. J., Li, L., & Puglielli, L. (2025). Overexpression of ATase1 and ATase2 disrupts the secretome and causes a progeria phenotype. Life Science Alliance. https://doi.org/10.26508/lsa.202503378

Vancouver

Cheng TL, Wu F, Haque ME, Thiel AR, Wang D, Helgager JJ, et al. Overexpression of ATase1 and ATase2 disrupts the secretome and causes a progeria phenotype. Life Science Alliance. 2025. doi:10.26508/lsa.202503378

BibTeX
@article{Cheng2025,
  author = {Cheng, Tzu-Lin and Wu, Feixuan and Haque, Md Ezazul and Thiel, Abigail R and Wang, Danqing and Helgager, Jeffrey J and Li, Lingjun and Puglielli, Luigi},
  title = {Overexpression of ATase1 and ATase2 disrupts the secretome and causes a progeria phenotype},
  journal = {Life Science Alliance},
  year = {2025},
  doi = {10.26508/lsa.202503378}
}
Kostenlos starten →